{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T18:37:53Z","timestamp":1786387073606,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.bone.2023.116925","type":"journal-article","created":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T04:22:59Z","timestamp":1696393379000},"page":"116925","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Denosumab treatment lapses, discontinuation, and off-treatment fracture risk: A retrospective study of patients with osteoporosis in a real-world clinical setting"],"prefix":"10.1016","volume":"177","author":[{"given":"Katie R.","family":"Cruchelow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan E.","family":"Peter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anwesa","family":"Chakrabarti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah M.","family":"Gipson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Taylor","family":"Gregory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"DeClercq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leena","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Bobo","family":"Tanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.bone.2023.116925_bb0005","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1002\/jbmr.2269","article-title":"The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine","volume":"29","author":"Wright","year":"2014","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.bone.2023.116925_bb0010","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1359\/jbmr.061113","article-title":"Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025","volume":"22","author":"Burge","year":"2007","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.bone.2023.116925_bb0015","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/oxfordjournals.aje.a008920","article-title":"Risk factors for osteoporotic fractures in elderly men","volume":"144","author":"Nguyen","year":"1996","journal-title":"Am. J. Epidemiol."},{"issue":"6","key":"10.1016\/j.bone.2023.116925_bb0020","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-137-6-200209170-00015","article-title":"Screening for postmenopausal osteoporosis: a review of the evidence for the U.S. Preventive Services Task Force","volume":"137","author":"Nelson","year":"2002","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bone.2023.116925_bb0025","series-title":"Prolia (denosumab) [package insert]","year":"2021"},{"issue":"4","key":"10.1016\/j.bone.2023.116925_bb0030","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1210\/jc.2010-1502","article-title":"Effects of denosumab treatment and discontinuation on bone mineral density and bone turnover markers in postmenopausal women with low bone mass","volume":"96","author":"Bone","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.bone.2023.116925_bb0035","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.bone.2023.116925_bb0040","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1359\/JBMR.040305","article-title":"A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women","volume":"19","author":"Bekker","year":"2004","journal-title":"J. Bone Miner. Res."},{"issue":"4","key":"10.1016\/j.bone.2023.116925_bb0045","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/jbmr.1808","article-title":"Discontinuation of denosumab and associated fracture incidence: analysis from the Fracture Reduction Evaluation of Denosumab in Osteoporosis Every 6 Months (FREEDOM) trial","volume":"28","author":"Brown","year":"2013","journal-title":"J. Bone Miner. Res."},{"issue":"5","key":"10.1016\/j.bone.2023.116925_bb0050","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1210\/jc.2019-00221","article-title":"Pharmacological management of osteoporosis in postmenopausal women: an endocrine society* clinical practice guideline","volume":"104","author":"Eastell","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2023.116925_bb0055","doi-asserted-by":"crossref","DOI":"10.1177\/20420188211010052","article-title":"Should denosumab treatment for osteoporosis be continued indefinitely?","volume":"12","author":"Noble","year":"2021","journal-title":"Ther. Adv. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2023.116925_bb0060","article-title":"Fracture risk and management of discontinuation of denosumab therapy: a systematic review and position statement by ECTS","author":"Tsourdi","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.bone.2023.116925_bb0065","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1007\/s00198-019-04963-2","article-title":"Long-term persistence in patients with osteoporosis receiving denosumab in routine practice: 36-month non-interventional, observational study","volume":"30","author":"Borek","year":"2019","journal-title":"Osteoporos. Int."},{"issue":"9","key":"10.1016\/j.bone.2023.116925_bb0070","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1007\/s00198-019-05051-1","article-title":"Denosumab utilization among older adults in Ontario: patient characteristics, persistence with therapy, and return to therapy after an extended gap","volume":"30","author":"Ban","year":"2019","journal-title":"Osteoporos. Int."},{"issue":"2","key":"10.1016\/j.bone.2023.116925_bb0075","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J. Biomed. Inform."},{"issue":"1","key":"10.1016\/j.bone.2023.116925_bb0080","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s11657-017-0351-2","article-title":"Factors associated with high 24-month persistence with denosumab: results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium","volume":"12","author":"Fahrleitner-Pammer","year":"2017","journal-title":"Arch. Osteoporos."},{"issue":"9","key":"10.1016\/j.bone.2023.116925_bb0085","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1002\/jbmr.4335","article-title":"Fractures after Denosumab discontinuation: a retrospective study of 797 cases","volume":"36","author":"Burckhardt","year":"2021","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.bone.2023.116925_bb0090","doi-asserted-by":"crossref","first-page":"165","DOI":"10.23736\/S0391-1977.20.03137-5","article-title":"Suboptimal medication adherence may favor the progression of vertebral fractures in women with post-menopausal osteoporosis treated with denosumab","volume":"45","author":"Betella","year":"2020","journal-title":"Minerva Endocrinol."},{"issue":"4","key":"10.1016\/j.bone.2023.116925_bb0095","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00198-021-06274-x","article-title":"COVID pandemic and denosumab adherence","volume":"33","author":"Minisola","year":"2022","journal-title":"Osteoporos. Int."},{"issue":"6","key":"10.1016\/j.bone.2023.116925_bb0100","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/jbmr.3110","article-title":"Clinical features of 24 patients with rebound-associated vertebral fractures after Denosumab discontinuation: systematic review and additional cases","volume":"32","author":"Anastasilakis","year":"2017","journal-title":"J. Bone Miner. Res."},{"issue":"5","key":"10.1016\/j.bone.2023.116925_bb0105","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1007\/s00198-015-3380-y","article-title":"Severe spontaneous vertebral fractures after denosumab discontinuation: three case reports","volume":"27","author":"Aubry-Rozier","year":"2016","journal-title":"Osteoporos. Int."},{"issue":"2","key":"10.1016\/j.bone.2023.116925_bb0110","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1210\/jc.2016-3170","article-title":"Severe rebound-associated vertebral fractures after denosumab discontinuation: 9 clinical cases report","volume":"102","author":"Lamy","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.bone.2023.116925_bb0115","doi-asserted-by":"crossref","first-page":"516","DOI":"10.7326\/M20-0882","article-title":"Delayed denosumab injections and fracture risk among patients with osteoporosis\u202f: a population-based cohort study","volume":"173","author":"Lyu","year":"2020","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.bone.2023.116925_bb0120","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1210\/clinem\/dgz321","article-title":"Delayed denosumab injections and bone mineral density response: an electronic health record-based study","volume":"105","author":"Lyu","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.bone.2023.116925_bb0125","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","article-title":"Clinician\u2019s guide to prevention and treatment of osteoporosis","volume":"25","author":"Cosman","year":"2014","journal-title":"Osteoporos. Int."},{"issue":"7","key":"10.1016\/j.bone.2023.116925_bb0130","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/jbmr.4305","article-title":"Treatment with Zoledronate subsequent to Denosumab in osteoporosis: a 2-year randomized study","volume":"36","author":"S\u00f8lling","year":"2021","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2023.116925_bb0135","doi-asserted-by":"crossref","first-page":"115830","DOI":"10.1016\/j.bone.2020.115830","article-title":"Risk factors for vertebral fractures and bone loss after denosumab discontinuation: a real-world observational study","volume":"144","author":"Everts-Graber","year":"2021","journal-title":"Bone"},{"issue":"Suppl. 2","key":"10.1016\/j.bone.2023.116925_bb0140","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/annrheumdis-2019-eular.4175","article-title":"OP0085 can we avoid the loss of bone mineral density one year after denosumab discontinuation? The reolaus bone project","volume":"78","author":"Aubry-Rozier","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.bone.2023.116925_bb0145","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1359\/jbmr.091112","article-title":"Smoking predicts incident fractures in elderly men: Mr OS Sweden","volume":"25","author":"Jutberger","year":"2010","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bone.2023.116925_bb0150","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00198-015-3290-z","article-title":"Smoking, smoking cessation, and fracture risk in elderly women followed for 10 years","volume":"27","author":"Thorin","year":"2016","journal-title":"Osteoporos. Int."},{"issue":"3","key":"10.1016\/j.bone.2023.116925_bb0155","doi-asserted-by":"crossref","first-page":"148","DOI":"10.22540\/JFSF-03-148","article-title":"Current and former smokers and hip fractures","volume":"3","author":"Ampelas","year":"2018","journal-title":"J. Frailty Sarcopenia Falls"},{"key":"10.1016\/j.bone.2023.116925_bb0160","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.2147\/DMSO.S191091","article-title":"Type 1 diabetes and bone fragility: links and risks","volume":"12","author":"Starup-Linde","year":"2019","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"10.1016\/j.bone.2023.116925_bb0165","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40842-018-0060-9","article-title":"Diabetes mellitus and bone health: epidemiology, etiology and implications for fracture risk stratification","volume":"4","author":"Valderr\u00e1bano","year":"2018","journal-title":"Clin. Diabetes Endocrinol."},{"key":"10.1016\/j.bone.2023.116925_bb0170","doi-asserted-by":"crossref","first-page":"115457","DOI":"10.1016\/j.bone.2020.115457","article-title":"The risk of hip and non-vertebral fractures in type 1 and type 2 diabetes: a systematic review and meta-analysis update","volume":"137","author":"Vilaca","year":"2020","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.bone.2023.116925_bb0175","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","article-title":"American Association of Oral and Maxillofacial Surgeons\u2019 position paper on medication-related osteonecrosis of the Jaws-2022 update","volume":"80","author":"Ruggiero","year":"2022","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.bone.2023.116925_bb0180","doi-asserted-by":"crossref","first-page":"115150","DOI":"10.1016\/j.bone.2019.115150","article-title":"Fracture incidence after denosumab discontinuation: real-world data from a large healthcare provider","volume":"130","author":"Tripto-Shkolnik","year":"2020","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.bone.2023.116925_bb0185","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.semarthrit.2019.02.007","article-title":"Spontaneous vertebral fractures after denosumab discontinuation: a case collection and review of the literature","volume":"49","author":"Florez","year":"2019","journal-title":"Semin. Arthritis Rheum."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328223002582?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328223002582?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T18:07:43Z","timestamp":1757614063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328223002582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":37,"alternative-id":["S8756328223002582"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2023.116925","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Denosumab treatment lapses, discontinuation, and off-treatment fracture risk: A retrospective study of patients with osteoporosis in a real-world clinical setting","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2023.116925","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116925"}}